| Authors: |
Wrzal PK; Medical Affairs, Novo Nordisk Canada, Inc, Mississauga, Ontario, Canada. Electronic address: pwz@novonordisk.com., Mohseni AA; Medical Affairs, Novo Nordisk Canada, Inc, Mississauga, Ontario, Canada., Fournier C; Clinique Médicale Cadillac, Montréal, Québec, Canada., Goldenberg R; LMC Diabetes & Endocrinology, Concord, Ontario, Canada., Hollahan D; Waterloo Wellington Diabetes, Cambridge, Ontario, Canada., Jin S; Pharmacy 101, Cobourg, Ontario, Canada., Pedersen SD; C-ENDO Endocrinology Centre, Calgary, Alberta, Canada., Vallis M; Family Medicine, Dalhousie University, Halifax, Nova Scotia, Canada., Bunko A; Real World Solutions, IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada., Myageri V; Real World Solutions, IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada., Kukaswadia A; Real World Solutions, IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada., Neish CS; Real World Solutions, IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada., Ivers NM; Department of Family Medicine, Women's College Hospital and University of Toronto, Toronto, Ontario, Canada. |